6FYP

X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/CX-4945 AT 2.29A

Summary for 6FYP

Entry DOI	10.2210/pdb6fyp/pdb
Related	6FYI 6FYK 6FYL 6FYO
Descriptor	Dual specificity protein kinase CLK3, 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid (3 entities in total)
Functional Keywords	splicing, transferase, kinase, tyrosine-protein kinase, serine/ threonine- protein kinase, nucleotide-binding
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	42604.07
Authors	Kallen, J. (deposition date: 2018-03-12, release date: 2018-07-18, Last modification date: 2024-01-17)
Primary citation	Kallen, J.,Bergsdorf, C.,Arnaud, B.,Bernhard, M.,Brichet, M.,Cobos-Correa, A.,Elhajouji, A.,Freuler, F.,Galimberti, I.,Guibourdenche, C.,Haenni, S.,Holzinger, S.,Hunziker, J.,Izaac, A.,Kaufmann, M.,Leder, L.,Martus, H.J.,von Matt, P.,Polyakov, V.,Roethlisberger, P.,Roma, G.,Stiefl, N.,Uteng, M.,Lerchner, A. X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome. ChemMedChem, 13:1997-2007, 2018 Cited by PubMed: 29985556 DOI: 10.1002/cmdc.201800344 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.29 Å)

Structure validation